Earlier Alzheimer’s Diagnosis May Be Possible with New Imaging Compound
Washington University in St. LouisResearchers have developed a chemical compound that detects the Alzheimer’s protein amyloid beta better than current FDA-approved agents. The compound potentially could be used in brain scans to identify the signs of Alzheimer’s early, or to monitor response to treatment.